Investigational drug (as of November 2002), a dual reuptake inhibitor for both serotonin and norepinephrine, being studied as an antidepressant and for control of pain and stress urinary incontinence.
Related categories 1
Manufacturer's site for this selective serotonin and norepinephrine reuptake inhibitor (SSNRI), approved in the US to treat diabetic peripheral neuropathic pain and major depression.
Duloxetine Antidepressant Action Begins in One Week
Report on study findings announced in October 2002. [MedScape - Free registration required.]
Features information about dosage, usage, warnings, and side effects.
Last update:October 17, 2016 at 22:58:21 UTC